Search details
1.
Adenovirus vectors activate Vδ2+ γδT cells in a type I interferon-, TNF-, and IL-18-dependent manner.
Eur J Immunol
; 52(5): 835-837, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34958459
2.
A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice.
Hepatology
; 76(4): 1190-1202, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35313015
3.
Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus.
Hepatology
; 71(3): 794-807, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31400152
4.
Divergent memory responses driven by adenoviral vectors are impacted by epitope competition.
Eur J Immunol
; 49(9): 1356-1363, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31106398
5.
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020.
Euro Surveill
; 25(42)2020 10.
Article
in English
| MEDLINE | ID: mdl-33094713
6.
Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge.
J Immunol
; 2017 Jul 19.
Article
in English
| MEDLINE | ID: mdl-28724579
7.
Different functions of the common P/V/W and V-specific domains of rinderpest virus V protein in blocking IFN signalling.
J Gen Virol
; 95(Pt 1): 44-51, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24158397
8.
Unlocking cancer vaccine potential: What are the key factors?
Hum Vaccin Immunother
; 20(1): 2331486, 2024 Dec 31.
Article
in English
| MEDLINE | ID: mdl-38564321
9.
HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.
JHEP Rep
; 5(11): 100885, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37791379
10.
NK cells limit therapeutic vaccine-induced CD8+T cell immunity in a PD-L1-dependent manner.
Sci Transl Med
; 14(640): eabi4670, 2022 04 13.
Article
in English
| MEDLINE | ID: mdl-35417187
11.
MAIT cell activation augments adenovirus vector vaccine immunogenicity.
Science
; 371(6528): 521-526, 2021 01 29.
Article
in English
| MEDLINE | ID: mdl-33510029
12.
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.
Nat Commun
; 12(1): 2055, 2021 04 06.
Article
in English
| MEDLINE | ID: mdl-33824342
13.
Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes.
Vaccine
; 38(32): 5036-5048, 2020 07 06.
Article
in English
| MEDLINE | ID: mdl-32532545
14.
The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV.
Vaccines (Basel)
; 8(2)2020 Apr 14.
Article
in English
| MEDLINE | ID: mdl-32295168
15.
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel.
Wellcome Open Res
; 5: 139, 2020.
Article
in English
| MEDLINE | ID: mdl-33748431
16.
The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes.
Vaccine
; 36(2): 313-321, 2018 01 04.
Article
in English
| MEDLINE | ID: mdl-29203182
17.
Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter.
Vaccine
; 34(1): 49-55, 2016 Jan 02.
Article
in English
| MEDLINE | ID: mdl-26616553
18.
Investigation of IRES Insertion into the Genome of Recombinant MVA as a Translation Enhancer in the Context of Transcript Decapping.
PLoS One
; 10(5): e0127978, 2015.
Article
in English
| MEDLINE | ID: mdl-26011541
19.
Morbillivirus v proteins exhibit multiple mechanisms to block type 1 and type 2 interferon signalling pathways.
PLoS One
; 8(2): e57063, 2013.
Article
in English
| MEDLINE | ID: mdl-23431397
Results
1 -
19
de 19
1
Next >
>>